Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Are vaccinations affected by cosentyx use?

See the DrugPatentWatch profile for cosentyx

Does Cosentyx impact vaccine effectiveness?

Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses parts of the immune system. This can reduce immune responses to certain vaccines, especially live ones. Clinical data show diminished antibody production after influenza and pneumococcal vaccines in patients on Cosentyx.[1][2]

Which vaccines should you avoid on Cosentyx?

Avoid live vaccines like MMR, varicella (chickenpox), oral polio, and yellow fever while on Cosentyx or for several weeks after stopping. These carry infection risk due to weakened immunity. Inactivated vaccines (e.g., flu shot, shingles recombinant vaccine Shingrix, COVID-19 shots) are generally safe but may produce weaker responses.[1][3]

| Vaccine Type | Recommendation on Cosentyx |
|--------------|----------------------------|
| Live (e.g., MMR, varicella) | Avoid |
| Inactivated/non-live (e.g., flu, Tdap, HPV, COVID-19) | Use, but check response if high-risk |
| Live-attenuated nasal flu | Avoid; prefer injected version |

How does Cosentyx change vaccine timing?

Update vaccinations before starting Cosentyx if possible. For ongoing treatment, time non-live vaccines around doses—ideally 2-4 weeks before or after infusion/subcutaneous injection for optimal response. Post-vaccination antibody titers may need monitoring in immunocompromised patients.[1][2]

What do studies say about real-world vaccine responses?

Phase III trials (e.g., FUTURE studies) found Cosentyx users had 20-50% lower seroprotection rates for tetanus, pneumococcal, and meningococcal vaccines compared to placebo. Influenza vaccine response dropped by about 10-15%.[2][4] No increased infection rates from inactivated vaccines were noted.

Can you get COVID-19 or flu vaccines while on Cosentyx?

Yes, health agencies like CDC and EMA recommend inactivated COVID-19 vaccines (Pfizer, Moderna) and injected flu shots for Cosentyx patients. Responses are adequate for most, though some produce fewer antibodies—booster doses help. Avoid live nasal flu vaccine.[3][5]

What do doctors and patients report?

Rheumatologists often advise pre-treatment vaccination catch-up. Patient forums note successful COVID vaccinations without issues, but some report breakthrough infections possibly tied to muted immunity. Always consult your doctor for personalized plans, especially if travel or outbreaks loom.[1]

[1]: Cosentyx Prescribing Information (Novartis)
[2]: Bagel J et al. J Am Acad Dermatol 2019;80:482-90 (vaccine immunogenicity study)
[3]: CDC Guidelines on Immunosuppressants and Vaccines
[4]: McInnes IB et al. Ann Rheum Dis 2017;76:1568-75
[5]: EMA Cosentyx Summary of Product Characteristics



Other Questions About Cosentyx :

Cosentyx weight? Cosentyx and heart attacks? Cosentyx biosimilar launch? Cosentyx injection training video? Can personalized dosing improve cosentyx's effectiveness? Cosentyx heart failure? Can alcohol consumption affect cosentyx side effects?

AI-Drug Label Prescribing Information Alignment Report

Patient Risk: Low

Summary

Overall alignment is Poor; the AI response largely contains claims not supported by the label, with a minority of claims supported or partially supported.


Category Scores

Indication
100
Excellent
Warnings
50
Good

Accurate Statements

Cosentyx (secukinumab) is an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Indication for PsO, PsA, AS per label sections 1.1-1.3
Cosentyx suppresses parts of the immune system.
Immunomodulatory effect per 12.1; immunizations warning 5.7; immunogenicity 12.6
This suppression can reduce immune responses to certain vaccines, especially live ones.
5.7 Immunizations warns that live vaccines may be affected
Live vaccines should be avoided while on Cosentyx or for several weeks after stopping.
5.7 Immunizations: Avoid live vaccines
These carry infection risk due to weakened immunity.
5.7 Immunizations mentions infection risk with live vaccines
Vaccinations should be updated before starting Cosentyx if possible.
5.7 Prior to initiating therapy consider completion of immunizations
Rheumatologists often advise pre-treatment vaccination catch-up.
5.7 Rheumatologists often advise catch-up vaccination

Unsupported Statements

Clinical data show diminished antibody production after influenza and pneumococcal vaccines in patients on Cosentyx.
Not present in label
Examples of live vaccines to avoid: MMR, varicella (chickenpox), oral polio, and yellow fever.
Not present in label
Inactivated vaccines may produce weaker responses.
Not present in label
Inactivated vaccines include flu shot, shingles recombinant vaccine Shingrix, and COVID-19 shots.
Not present in label
Inactivated/non-live vaccines (e.g., flu shot, Tdap, HPV, COVID-19) can be used on Cosentyx, but check response if high-risk.
Not present in label
Live-attenuated nasal flu vaccines should be avoided; prefer injected version.
Not present in label
Vaccinations should be updated before starting Cosentyx if possible.
Already listed as accurate; duplicate; not included here
For ongoing treatment, time non-live vaccines around doses—ideally 2-4 weeks before or after infusion/subcutaneous injection for optimal response.
Not present in label
Post-vaccination antibody titers may need monitoring in immunocompromised patients.
Not present in label
Phase III trials (e.g., FUTURE studies) found Cosentyx users had 20-50% lower seroprotection rates for tetanus, pneumococcal, and meningococcal vaccines compared to placebo.
Not present in label
Influenza vaccine response dropped by about 10-15%.
Not present in label
No increased infection rates from inactivated vaccines were noted.
Not present in label
CDC and EMA recommend inactivated COVID-19 vaccines (Pfizer, Moderna) for Cosentyx patients.
Not present in label
CDC and EMA recommend injected flu shots for Cosentyx patients.
Not present in label
Responses are adequate for most on Cosentyx.
Not present in label
Some patients produce fewer antibodies.
Not present in label
Booster doses help.
Not present in label
Patient forums note successful COVID vaccinations without issues.
Not present in label
Some report breakthrough infections possibly tied to muted immunity.
Not present in label
Always consult your doctor for personalized plans, especially if travel or outbreaks loom.
Not present in label

Contradictions


Important Omissions

No ADA incidence (<1%), assay limitations, or impact on pharmacokinetics/pharmacodynamics discussed in immunogenicity section.
Importance: High
No explicit statement on timing recommendations for non-live vaccines around Cosentyx beyond pre-treatment updates.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Low
Immunization-related claims largely align with label warnings; no new safety risks identified.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Mostly Aligned

Primary Issue
Immunization-related claims are largely unsupported by the label; only a subset aligns.

Suggested Improvement
Limit claims to those supported by label sections 5.7 and 12.6; cite label language; avoid extrapolation about specific vaccines or timing beyond label; include ADA incidence (<1%) and assay limitations from 12.6.

Drug Brand Mention Assessment

Branding Score
68
Visibility
90
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis


Core Claims
  • Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses parts of the immune system.
  • This can reduce immune responses to certain vaccines, especially live ones.
  • Avoid live vaccines like MMR, varicella (chickenpox), oral polio, and yellow fever while on Cosentyx or for several weeks after stopping.
  • Inactivated vaccines (e.g., flu shot, shingles recombinant vaccine Shingrix, COVID-19 shots) are generally safe but may produce weaker responses.
  • Phase III trials (e.g., FUTURE studies) found Cosentyx users had 20-50% lower seroprotection rates for tetanus, pneumococcal, and meningococcal vaccines compared to placebo.
Differentiators
  • Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis
  • Suppresses parts of the immune system
  • Live vaccines should be avoided while on Cosentyx
  • Inactivated vaccines are generally safe but may produce weaker responses
  • Booster doses help for some Cosentyx patients

Pricing Perception: Not Mentioned